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Non-invasive circulating nucleic acids-based tumor diagnostics:
Looking for epigenetic markers
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Epigenetic biomarkers including aberrantly methylated DNA
(amDNA) and non-coding RNA such as microRNAs (miRNAs)
and long non-coding RNAs (lncRNAs) in biological fluids repre-
sent markers with the highest potential for cancer diagnostics.
Tumor-specific amDNA is more easily and efficiently detected in
blood plasma/serum in presence of large excess of wild type
DNA compared with mutated DNA. miRNAs are much more
stable than coding mRNA and are present in blood in detectable
amounts. However still only a few cell-free DNA (cfDNA) -based
diagnostics detecting epigenetic markers have come to the
market. The main limitations of aberrantly methylated cfDNA
(am-cfDNA) markers are age- and tissue-specific DNA methyla-
tion, low concentration of tumor-specific DNA along with pres-
ence of any conceivable methylated DNA pattern in circulation
(Korshunova, 2009). Potential miRNA markers selection demands
large scale primary analysis and overcoming some analytical
complication like efficiency and uniformity of miRNA isolation
and normalization at verification step.
To overcome limitations of am-cfDNA use we utilized two
approaches:
Biased comprising selection of markers valid for tumor
tissues, elaboration of the demands for inclusion/exclusion of
cfDNA samples, development of PCR with absolute specificity
and sensitivity of 1–10 molecules per sample, increasing of
cfDNA concentration in the analytical sample. Epigenomics
GA successfully used this approach for the EpiColon test
development.
Unbiased comprising search for potential markers in cfDNA/
cfRNA using modern methods including MPS and subsequent
bioinformatics data analysis, formulation of the requirements
to analytical systems based on MPS data, development and
validation of the diagnostics.
Using first approach we selected 4 markers from 5 studied
which proposed diagnostic value for lung cancer. Analytical sen-
sitivity of methyl-specific TagMan PCR for these 4 genes and a
control gene are 2, 3, 4, 10 and 10 copies of methylated DNA in
1000-fold excess of unmethylated DNA, correspondingly.
Diagnostic sensitivity of lung cancer detection in the training
group (30 healthy, 30 lung cancer patients, training cohort) for 4
genes are 13%, 46%, 73%, 30%, specificity – 100%, 97%, 100%,
97%, respectively. Inclusion/exclusion criteria are based on a
control gene concentration in blood plasma. 2 markers in
combination provide 89%sensitivity of lung cancer diagnostics
and 97% specificity, 3 markers in combination demonstrate
sensitivity and specificity of 92% and 97%.
Unbiased approach included locus-specific MPS using MiSeq
platform of 2 aberrantly methylated genes amplified with
methyl-independent primers (barcoded individually) after bisul-
fite conversion of cfDNA isolated from blood of 18 healthy donors
(HD), 20 prostate cancer (PC) and 17 benign prostatic hyperplasia
patients (BPH). Analysis of individual methylation patterns and
their representation demonstrates that methylation of GSTP1
gene-located 4 CpG-pairs in cfDNA from healthy donors differs
compared with PC patients. Logistic regression-based model of
4 CpG-pairs methylation demonstrates 95% specificity and 100%
sensitivity of PC diagnostics.
Looking for miRNA markers 20 primary lung cancer patients
(14 – squamous cell carcinoma, 6 – adenocarcinoma) and 10
healthy donors were enrolled in the study (training cohort). Circu-
lating miRNAs were isolated by one-step phenol-free protocol
(Zaporozhchenko et al., 2015). Concentrations of 179 miRNAs
were measured in circulating miRNA pool by miRCURY LNA
microRNA PCR Serum/Plasma Panel (Exiqon Ltd, Denmark). 18
miRNAs were differentially expressed between groups of healthy
donors and patients with squamous cell carcinoma. 2 miRNAs
provide 85% and 79% diagnostic sensitivity with 100% specificity.
Verification using qRT-TaqMan PCR on a testing cohort including
75 lung cancer patients (squamous cell carcinoma and adenocar-
cinoma) and 50 healthy donors demonstrates 66% sensitivity and
89% specificity of the best selected miRNA.
In conclusion, wide scale modern methods demonstrate high
efficacy for epigenetic cfNA cancer markers development,
whereas conventional approaches based on the current experi-
ence have not yet exhausted their potential.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.067
A92
Immune unresponsiveness to cytokine changes at immunomodula-
tion of brain tumor patients
M. Mukhacheva*, B. Beyn. Kirov State Medical Academy, Kirov,
Russian Federation
⇑
Corresponding author.
This work is devoted to the actual problem of studying modern
ideas about the systemic treatment of brain tumors, in particular
on the implementation and effectiveness of modern methods of
immunomodulation in neuro-oncology. The aim is to clarify the
existence of patients with brain tumors immunosuppression,
resulting in testimony to the development and application of
methods of immunotherapy. Method of research consistent with
the goal and objectives of the study, which included a dynamic
examination of 32 operated patients with hemispheric brain glio-
mas. Cycloferon interferonogens from the group, which has
antiviral and antitumor action potential was used as an
immunomodulator us. It is of interest to determine the effective-
ness of immunomodulatory action of cycloferon in patients with
brain tumors in different phases of development of cancer. This
work represents a scientific novelty and practical significance
for solving urgent problems of neurology and neurosurgery –
the study of the cycloferon drug, has proved its effectiveness in
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the reinforcement of clinical remission and increased the life
expectancy of patients with brain tumors after surgery.
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Objective: To study the impact of oxidative stress acute
hypoxia and reperfusion on HeLa cervical cancer cell attachment,
survival and invasion capacities.
Summary background data: Many hypotheses have been pro-
posed to explain the mechanism of port-site metastases (PSM).
We presumed that CO2 exposure results in hypoxia and reperfu-
sion with subsequent oxidative stress of cancer cells being a trig-
gering mechanism of PSM.
Methods: Two CO2-pneumoperitoneum conditions were cre-
ated: the hypoxic standard model (HSM) and oxidative stress
model (OSM) upon CO2 insufflation and reperfusion by means
of in vitro cell culture tools and non-exposed cells were served
as intact control. HeLa cervical cancer cells were exposed under
these CO2 insufflation conditions. Subsequently, HeLa cell
attachment, viability and proliferation capacities were evaluated
in duplicate samples as series I and II by the MTT and SRB
assays and invasion by the Matrigel invasion assay and repeated
in triplicate experiments. The impact of different CO2-
pneumoperitoneum conditions on cancer cell attachment was
evaluated immediately after exposure, whereas invasion capacity
after 48 h of incubation and survival and proliferation every 24 h
for 72 h.
Results: Both CO2 insufflation models significantly affected
HeLa cell attachment activity (p < 0.001) in comparison with that
of non-exposed cells. CO2 insufflation by HSM resulted in signif-
icantly pronounced weakening of HeLa cell attachment as com-
pared to exposure of these cells to insufflation by OSM
(p < 0.001). Both pneumoperitoneum regimes significantly weak-
ened HeLa cell invasion capacity in comparison with those of
controls (p < 0.001 and p < 0.05), whereas HSM profoundly
decreased HeLa cell invasion capacity in comparison with that
of OSM (p < 0.05).
Conclusion: An in vitro model of oxidative stress during CO2-
pneumoperitoneum increased HeLa cancer cell invasion capacity
in comparison with standard CO2-pneumoperitoneum condition
with continuous CO2 insufflation. Oxidative stress followed by
acute hypoxia and reperfusions during deflations can increase
cancer cell attachment and survival capacity, and may trigger
cancer cell invasion and metastasis. These data suggest that a
regime of laparoscopic procedures may affect attachment and
invasion of cancer cells and hence can explain the occurrence
of port-site cancer metastasis.
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Obesity, associated with metabolic syndrome, is considered a
significant risk factor for colorectal cancer (CRC).
Purpose: To compare the levels of metabolic syndrome (MS)
components in persons with CRC and control in the frame of
nested ‘‘case-control” design.
Materials and Methods: The study was carried out on the basis
of a comparison of databases from epidemiological study The
HAPIEE project and CRC register. The patients examined in the
HAPIEE project, who had developed CRC during 10-year follow-
up period according to the register of cancer (n = 92, men-48,
women-44, mean age 60.7 + 6.9 years) were included in analysis.
The control group, matched by sex and age, was also formed from
the HAPIEE database (n = 184, men-96, women-88, mean age
60.7 + 6.8 years). We used MS criteria’s according to NCEP
ATP – III (2001). The data was processed using statistical program
SPSS 13.0.
Results: Body mass index (BMI) and waist circumference (WC)
had no significant differences in the studied groups, the average
BMI value in CRC group was 28.6 + 5.3 kg/m2 vs 28.4 + 5.6 kg/m2
in control (p = 0.70) and WC value in CRC group was
94.1 + 11.7 cm vs 94.1 + 13.6 cm in control (p = 0.90). The percent-
age of patients with abdominal obesity was 41.3% in patients with
CRC vs 42.9% in the control group (p = 0.70).
The average value of total cholesterol was equally high in both
groups (246.8 + 52.5 mg/dL in patients with CRC and 239.8
+ 47.0 mg/dL in the control group), with large individual variation
but no significant difference (p = 0.27). The average level of HDL
cholesterol in CRC group was within normal limits and also did
not differ from control (p = 0.60). The average level of TG in CRC
patients was slightly lower than in the control group:
127.2 + 58.5 mg/dl vs 144.6 + 80.8 mg/dL (p = 0.07). The average
level of glucose did not differ in patients with CRC and in control:
5.9 + 1,2 mmol/l vs 6.1 + 2.1 mmol/L (p = 0.40). In patients with
CRC systolic blood pressure was significantly lower than in con-
trol group: 142.1 + 21.3 mmHg vs 150.4 + 23.7 mmHg (p = 0.005).
The level of diastolic blood pressure was slightly lower than in
the control group compared to CRC (88.9 + 11.2 mmHg
vs91.9 + 13.4 mmHg, p = 0.06). The proportions of patients with
low HDL cholesterol, hypertriglyceridemia and hyperglycemia
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